Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma.
Sun
S S
SS
Department of Nuclear Medicine, China Medical College Hospital, Taichung, Taiwan.
Tsai
S C
SC
Hsieh
J F
JF
Lee
J K
JK
Kao
C H
CH
D000368:Aged; D001859:Bone Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000556:secondary*; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D010148:Intractable Pain / Q000209:etiology* / Q000532:radiotherapy*; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000473:pathology*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes / Q000627:therapeutic use; D013669:Technetium Tc 99m Medronate
D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes; D013669:Technetium Tc 99m Medronate